Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Sarcoma 1Other solid neoplasm 1Other hematologic neoplasm 1Lymphoid 1

Conditions

Advanced Solid Tumors 4Solid Tumor 3Wilms Tumor 1Solid Tumours 1Solid Tumour 1Solid Tumors 1Solid Tumor, Adult 1Sarcoma, Synovial 1Sarcoma 1Rhabdoid Tumor 1Retinoblastoma 1Refractory or Relapsed Solid Tumors 1Neuroblastoma 1Mycoses 1Mesothelioma 1Lymphoma, Non-Hodgkin 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Hematologic Neoplasms 1Brain Neoplasms 1Advanced Solid Tumours 1

Interventions

tazemetostat 3pembrolizumab 1cixutumumab 1Rifampin 1Quality of Life 1Patient Reported Outcome Measures 1Molecular Diagnostic Techniques 1Itraconazole 1Immunotherapy, Adoptive 1Immunotherapy 1Imatinib Mesylate 1Drug Therapy 1Biological Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Sarcoma, Synovial × Itraconazole × Other solid neoplasm × Clear all
NCT04537715 2025-02-19

Effects of Itraconazole and Rifampin on the Blood Tazemetostat Levels

Ipsen

Phase 1 Completed
42 enrolled 39 charts
LymphoidOther hematologic neoplasmOther solid neoplasmSarcomaThoracic

Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Mesothelioma, Sarcoma, Sarcoma, Synovial, Lymphoma, Large B-Cell, Diffuse, Rhabdoid Tumor, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡